Spatial Genomics Market to Observe Utmost CAGR of 11.6% by 2030

Published July 21, 2023

Global Spatial Genomics Market research report estimates potential market for new product, consumer’s reaction for particular product, general market tendencies, different types of customers, and intensity of marketing problem. The market report has been generated by keeping in mind all the vital aspects of the market research that simply brings market landscape into focus. By examining competitor analysis, Healthcare industry can get fluency of the strategies of key players in the market that includes new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions. An all-inclusive Global Spatial Genomics Market report displays CAGR value fluctuation during the forecast period of 2023-2030 for the market.

Breast cancer is one of the most common cancers in the world. Breast cancer has the highest incidence of all cancers in women, according to a study published in January 2020. The study also stated that the annual incidence rate of breast cancer was over 1.6 million cases. This necessitates the use of early diagnostic procedures, which is where the role of particular genomics comes into play.

Data Bridge Market Research analyses that the spatial genomics market which is USD 204.01 million in 2022, is expected to reach USD 490.86 million by 2030, at a CAGR of 11.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @

Market Definition

Spatial genomics is the study of the entire set of genetic commands provided by DNA to detect and diagnose cancer tumour cells. Spatial genomics is used in disease control because it provides quantitative gene expression data. Spatial genomics also provides information on visualizing DNA and RNA mapping into tissue components.


  • Rising applications of genomics

The increasing use of genomics and transcriptomics by academic institute researchers is one factor driving market growth. These techniques are widely used for the comprehensive evaluation of a wide range of diseases. For instance, a research institute like Children’s Hospital for Philadelphia has experience in both locus discovery and GWAS in both academic and biotech settings. These have established a longitudinal and functional genomics centre to study the genetics of various diseases and the morphology of diseases resulting from genetic disorders such as cancer, diabetes, and Alzheimer’s. Furthermore, genomic and transcriptomics technology has broader applications in the sector, such as the Human Cell Atlas. These are the certain factors which propel the market.

  • Increasing consumable adoption

Consumable’s is significantly boosting the spatial genomics and transcriptomics market in the forecast period with a market share of 57.2% in 2021. The market’s expansion is attributed to factors such as high product penetration, increasing consumable adoption, frequent use of kits and reagents for instruments in genomics and transcriptomics, and the wide availability of consumables. These instruments are used to prepare sample specimens for genomic mapping. Furthermore, advancements and new features in the consumables segment are increasing the adoption of biopharmaceuticals and research activities.

Recent Developments

  • In 2020, Cancer Transcriptome Atlas, a new product based on NanoString Technologies’ GeoMx Digital Spatial Profiler (DSP) platform, is optimized for readout on Illumina’s next-generation sequencing (NGS) technology, is available.
  • In 2020, S2 Genomics launched the Singulator 100 System, which automates the processing of solid tissue samples into suspensions of single cells or nuclei with high yields and from small samples for a variety of single-cell biology and genomic analyses.

Some of the major players operating in the spatial genomics market are:

  • Thermo Fisher Scientific Inc. (U.S.)
  • 10X Genomics (U.S.)
  • NanoString Technologies Inc. (U.S.)
  • Illumina Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • QIAGEN (Netherlands)
  • Agilent Technologies, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • S2 Genomics, Inc. (U.S.)
  • Seven Bridges Genomics (U.S.)
  • CARTANA AB (Sweden)
  • Advanced Cell Diagnostics, Inc. (U.S.)
  • Dovetail Genomics (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Merck & Co., Inc. (Germany)
  • Novo Nordisk A/S (Denmark)
  • Amgen Inc. (U.S.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Gsk plc (U.K.)
  • Bayer AG (Germany)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@

Top Key Topics Covered:

  1. Strategic Imperatives
  • Factors Creating Pressure on Growth
  • The Strategic Imperative
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology
  1. Scope and Segmentation
  • Research Context and Scope of Analysis
  • Segmentation
  • Other Techniques for This Research Report Management
  1. Growth Opportunity Analysis
  • Growth Drivers
  • Growth Restraints
  1. Introduction
  • The Impact of the COVID-19 Pandemic and Post
  • Future Growth
  1. Innovation Ecosystem


Spatial Genomics Market Scope

The spatial genomics market is segmented on the basis of technology, end-user, product, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Fluorescence in situ hybridization (FISH)
  • Microscopy-based Live DNA Imaging
  • Genome Perturbation Tools
  • Massively-Parallel Sequencing
  • Biochemical Techniques
  • Others


  • Instruments
  • Consumables
  • Software


  • Translational Research
  • Academic Customers
  • Diagnostic Customers
  • Pharmaceutical Manufacturer
  • Government Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations


  • Diagnostics and Disease Profiling
  • Drug Discovery
  • Others

Fundamental Aim of this Market Report

  • Notable Market rivals around the world.
  • Future Scope and Product Outlook
  • Future-promising emerging markets.
  • The Market Presents Difficult Challenges and Threats.

Key highlights of this Market report:

  • Major restraints
  • Market drivers
  • Regional bifurcation
  • Competitive hierarchy
  • Current market tendencies
  • Market concentration analysis

Browse the complete table of contents at –

Critical Insights Related to the adalimumab biosimilar Included in the Report:

    • Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
    • Value chain analysis of prominent players in the market
    • Current trends influencing the dynamics of this market across various geographies
    • Recent mergers, acquisitions, collaborations, and partnerships
    • Revenue growth of this industry over the forecast period
    • Marketing strategy study and growth trends
    • Growth-driven factor analysis
    • Emerging recess segments and region-wise market
    • An empirical evaluation of the curve of this market
    • Ancient, Present, and Probable scope of the market from both prospect value and volume

Top DBMR Healthcare Reports:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


CDN Newswire